Mark Bunting

Dr Mark Bunting

Postdoctoral Researcher - SAiGENCI

South Australian Immunogenomics Cancer Institute

Faculty of Health and Medical Sciences


Dr. Mark Bunting is a post-doctoral researcher in the Hormone Dependent Cancers Laboratory at the South Australian immunoGENomics Cancer Institute (SAiGENCI). The lab is directed by Prof. Christopher Sweeney.

Dr. Mark Bunting completed his Ph.D. in Immunology at the University of Adelaide in 2012. He then joined the lab of Prof. Geoff Hill at the QIMR Berghofer Medical Research Institute in Brisbane, Australia studying the role of mucosal associated invariant T cells (MAIT) and natural killer cells in graft-versus-host disease and leukemia preclinical models. He then undertook a second post-doctoral position in the lab of Assistant Prof. Shawn Demehri at the Massachusetts General Hospital & Harvard Medical School in Boston, USA. Here he researched the role of natural killer cells in solid organ transplantation and skin cancer preclinical models. In 2019 he moved back to Adelaide and joined the Genome Editing Laboratory to explore the use of CRISPR/Cas9 for genome editing.

Dr. Bunting's current research at the South Australian immunoGENomics Cancer Institute (SAiGENCI) in the lab of Prof. Christopher Sweeney is focused on expanding our understanding of hormone-dependent cancer pathogenesis and identifying therapeutic targets.

My current research is centered on expanding our understanding of prostate cancer pathogenesis.

  • Position: Postdoctoral Researcher - SAiGENCI
  • Phone: 83130995
  • Email: mark.bunting@adelaide.edu.au
  • Campus: West End Health Precinct
  • Building: AHMS - Adelaide Health and Medical Sciences, floor Eighth Floor
  • Org Unit: South Australian Immunogenomics Cancer Institute

Connect With Me
External Profiles